Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

See all formats and pricing
In This Section
Volume 36, Issue 1 (Jan 1998)


Quantitation of IgG and IgM Human Anti-Mouse Antibodies (HAMA) Interference in CA 125 Measurements Using Affinity Chromatography

Norbert P. Koper / Chris M. G. Thomas / Leon F. A. G. Massuger / Martin F. G. Segers / André J. Olthaar / André L. M. Verbeek
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.005


Currently no available immunoassay system offers complete protection against spuriously elevated or lowered results due to interference by Human Anti-Mouse Antibodies (HAMA). Although routine use of chromatography procedures is not an acceptable option because of the extra cost and workload involved, such a procedure would be highly desirable to ensure accurate immunoassay results. The present report describes a relatively simple affinity chromatography procedure using a HiTrap Protein G column to isolate immunoglobulin G (IgG) HAMA, followed by a HiTrap N-hydroxy-succinimide(NHS)-activated column coupled to goat-anti human immunoglobulin M (IgM) to bind IgM HAMA. To examine the usefulness of this purification procedure we determined CA 125 in forty serum samples prior to and following chromatography. Pre- and post-injection samples were obtained from 20 patients injected with 1 mg of 111In-Iabelled murine OC 125 F(ab′)2 fragments in an immunoscintigraphy study.

It is shown that this analytical procedure provides a technique to determine the extent and the nature of the existing HAMA interference in samples of patients after in vivo use of monoclonal antibodies for diagnostic or therapeutic purposes. The procedure can also contribute to the clarification of clinically discordant CA 125 results. Finally, the availability of such a procedure in the clinical laboratory provides an opportunity to test the robustness of newly developed immunoassay systems towards HAMA interference.

About the article

Published Online: 2005-06-01

Published in Print: 1998-01-30

Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.005. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Norbert P. Koper, Leon F.A.G. Massuger, Chris M.G. Thomas, Cornelis Beyer, and Marinus J. Crooy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999, Volume 86, Number 2, Page 203
Angèle L.M. Oei, Fred C.G.J. Sweep, Leon F.A.G. Massuger, André J. Olthaar, and Chris M.G. Thomas
Gynecologic Oncology, 2008, Volume 109, Number 2, Page 199
Chris MG Thomas, Leon FAG Massuger, and Hans MWM Merkus
The Lancet, 2000, Volume 355, Number 9216, Page 1725
A. K. Knight, T. Bingemann, L. Cole, and C. Cunningham-Rundles
Clinical and Experimental Immunology, 2005, Volume 141, Number 2, Page 333

Comments (0)

Please log in or register to comment.
Log in